Relentless Venture Fund is an early-stage venture capital firm based in Vancouver, Canada, established in 2008. The fund focuses on investing in preventative and proactive technology solutions that enhance health, activity, and longevity. It targets a diverse range of sectors, including healthcare, digital health, health technology, manufacturing, and wellness. By investing primarily in the United States and Canada, Relentless Venture Fund aims to support innovative companies that optimize health outcomes through advanced technology.
Modality.AI, Inc. specializes in AI-driven healthcare screening solutions that focus on monitoring and assessing patients' health through conversational interactions. The company's platform utilizes audio-visual biomarkers and engages patients via dialogue and video to provide continuous health assessments. This technology is particularly beneficial for pharmaceutical companies, as it enhances the efficiency of clinical trials for therapies targeting neurological and mental health conditions. By analyzing multimodal data, Modality.AI delivers objective measures that correlate with clinical outcomes, facilitating self-driven neurological assessments. Founded in 2018 and headquartered in San Francisco, California, Modality.AI aims to improve health evaluations and streamline the clinical trial process.
Modality.AI
Seed Round in 2022
Modality.AI, Inc. specializes in AI-driven healthcare screening solutions that focus on monitoring and assessing patients' health through conversational interactions. The company's platform utilizes audio-visual biomarkers and engages patients via dialogue and video to provide continuous health assessments. This technology is particularly beneficial for pharmaceutical companies, as it enhances the efficiency of clinical trials for therapies targeting neurological and mental health conditions. By analyzing multimodal data, Modality.AI delivers objective measures that correlate with clinical outcomes, facilitating self-driven neurological assessments. Founded in 2018 and headquartered in San Francisco, California, Modality.AI aims to improve health evaluations and streamline the clinical trial process.
LUCID
Seed Round in 2022
LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. The company is creating experiences to assist consumers and employers all over the world in better managing anxiety and stress. They have created wellness-focused experiences that deliver benefits in as little as 5 minutes using innovative human-centered design at the intersection of art, science, and technology.
ClaimBuddy
Seed Round in 2022
ClaimBuddy is the operator of a medical support firm that aims to provide a one-stop shop for claim help for patients and hospitals. The company provides individualized claim help through its in-house advisors, who examine customers' medical insurance and handle their questions, allowing clients to ensure hassle-free insurance claims by employing technology.
WayFr
Seed Round in 2021
WayFr is a mobile application that instantly enables shippers and freight brokers to create their personalized load-board (load posting platform) that they can use to receive price quotes and book trucks within their network of carriers. Brokers and Shippers can additionally leverage WayFr registered carrier networks and social media groups to find trucks from outside of their own network.
Modality.AI
Seed Round in 2021
Modality.AI, Inc. specializes in AI-driven healthcare screening solutions that focus on monitoring and assessing patients' health through conversational interactions. The company's platform utilizes audio-visual biomarkers and engages patients via dialogue and video to provide continuous health assessments. This technology is particularly beneficial for pharmaceutical companies, as it enhances the efficiency of clinical trials for therapies targeting neurological and mental health conditions. By analyzing multimodal data, Modality.AI delivers objective measures that correlate with clinical outcomes, facilitating self-driven neurological assessments. Founded in 2018 and headquartered in San Francisco, California, Modality.AI aims to improve health evaluations and streamline the clinical trial process.
Orpyx Medical Technologies
Series A in 2020
Orpyx Medical Technologies Inc. specializes in developing mobility sensor devices aimed at diabetic patients. The company's flagship product, the Orpyx SI sensory insoles, employs advanced sensor technology to monitor pressure, temperature, and movement, thereby helping to manage and prevent diabetic foot ulcers and limb loss. Additionally, Orpyx offers Kinetyx, a mobile in-shoe pressure management system that captures clinical plantar pressure data for sports medicine and footwear design, along with SurroGait Rx, which aids multiple sclerosis patients in enhancing mobility and balance. Founded in 2010 and headquartered in Calgary, Canada, Orpyx Medical Technologies is committed to empowering individuals with diabetes to maintain their mobility while promoting a prevention-focused healthcare model.
Snapclarity
Venture Round in 2019
Snapclarity Inc. is a digital mental health platform based in Ottawa, Canada, that offers online mental health assessment and support services. Founded in 2016, the company connects users with therapists tailored to their individual needs through text messages and live video sessions. Snapclarity's innovative platform employs algorithms to assess users' risk levels and develop immediate, personalized treatment plans. This approach has been shown to significantly improve outcomes, with 86.5% of clients reporting enhancements in various life functions within 16 weeks. The company aims to streamline mental health care and enhance treatment coordination by linking clients to the appropriate professionals quickly and efficiently. As of October 2020, Snapclarity operates as a subsidiary of CloudMD Software & Services Inc.
ePACT Network
Series A in 2019
ePACT Network Ltd. operates a communication and emergency preparedness platform in Canada, designed to enhance safety and preparedness for organizations and families. Founded in 2012 and based in North Vancouver, the company offers a service that allows users to create networks with relatives, friends, and organizations, facilitating the secure sharing of critical information and access to communication tools during emergencies. By connecting homes and organizations, ePACT promotes improved emergency preparedness across North America, enabling users to navigate unexpected situations more effectively. This platform not only helps users manage crises but also aims to foster safer communities through shared resources and information.
Canary Medical
Venture Round in 2018
Canary Medical Inc. focuses on developing innovative medical implant and data management devices that facilitate remote patient monitoring and data collection. Founded in 2013 and based in Vancouver, Canada, the company has created the Canary Health Implantable Reporting Processor (CHIRP), a sensor-based device that autonomously gathers medical data without requiring significant patient compliance or physician intervention. In 2021, it launched canturio™te, the first "smart knee" tibial extension, which continuously monitors patient activity and joint performance, transmitting the collected data to the cloud. Canary Medical aims to enhance healthcare outcomes while reducing costs by providing reliable and efficient healthcare data monitoring and analysis. The company is backed by a team of experienced professionals with expertise in medical device design, development, and data informatics.
Aspect Biosystems
Venture Round in 2017
Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, focused on 3D bioprinting and tissue engineering. Founded in 2013, it develops bioprinted tissue therapeutics aimed at transforming disease treatment. The company utilizes proprietary microfluidic 3D bioprinting technology to create physiologically relevant living tissues, allowing for precise control over biomaterial composition and structure during fabrication. Aspect Biosystems offers contract testing services using its 3DAirwayALI human tissue model, catering to pharmaceutical firms and academic institutions engaged in research related to respiratory diseases. Through partnerships with leading researchers and industry innovators, the company aims to address significant challenges in regenerative medicine and advance the understanding of human tissue creation for medical research and therapeutic discovery.
Wiivv
Series A in 2017
Wiivv (pronounced weave) is a technology company transforming footwear, apparel, and wearables for every human body, so that you can move and live your best. Wiivv Insoles and Sandals are created uniquely for you, based on measurements taken from the award-winning Wiivv app. All Wiivv products are designed to enhance and support your unique anatomy. The stack combines advanced capture technology, biomechanics research, CV, AI, ML, and a proprietary customization platform deigned to output on-demand digitally manufactured and 3DP products. Wiivv also partners with brands and creators to scale the rapid customization of their product categories powered by Wiivv Fit Technology.
Newtopia
Series A in 2016
Newtopia Inc. is a health technology company based in Toronto, Canada, that focuses on habit change to reduce metabolic risk and prevent chronic diseases. Founded in 2008, Newtopia utilizes a proprietary virtual platform that combines personal genetics with social and psychological insights to create personalized health plans. By addressing unhealthy lifestyles, the company aims to mitigate the economic and social consequences associated with obesity, chronic diseases, and aging. Newtopia's innovative health engagement platform encourages individuals to make healthier lifestyle choices, demonstrating a proven model with an 80% success rate among early clients. The company targets partnerships with insurers, self-insured employers, and brands, offering sustainable health outcomes and a significant return on investment, making it a promising B2B collaborator in the health sector.
TritonWear
Seed Round in 2016
TritonWear Inc. is a Canadian company based in Kitchener that specializes in developing performance wearables for athletes and coaches. Its innovative devices offer real-time tracking of athletic performance through mobile technology, addressing challenges in the sports wearables market, particularly issues related to data accuracy and the lack of actionable feedback. TritonWear's products feature patented technology and AI-based auto-coaching capabilities, which automatically calculate performance metrics and provide personalized insights. This allows coaches to monitor their athletes' progress throughout training and competitions, guiding them on specific areas for improvement. By focusing on these critical needs, TritonWear aims to enhance the athletic experience and redefine the limits of performance.
Epact
Seed Round in 2016
Epact offers cloud-based services for managing legal signatures. They have capabilities like review management, multiple signers, multi-document sending, encrypted document storage, management of the AES algorithm, management of digital signatures, contract editor, management of cases, management of third-party integrations, etc.
ePACT Network
Seed Round in 2016
ePACT Network Ltd. operates a communication and emergency preparedness platform in Canada, designed to enhance safety and preparedness for organizations and families. Founded in 2012 and based in North Vancouver, the company offers a service that allows users to create networks with relatives, friends, and organizations, facilitating the secure sharing of critical information and access to communication tools during emergencies. By connecting homes and organizations, ePACT promotes improved emergency preparedness across North America, enabling users to navigate unexpected situations more effectively. This platform not only helps users manage crises but also aims to foster safer communities through shared resources and information.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.